Should lymphangioleiomyomatosis patients be permitted to donate blood?

Eur Respir J. 2016 Jun;47(6):1883-4. doi: 10.1183/13993003.00410-2016. Epub 2016 Apr 21.

Authors

Anne F Eder¹, Jay H Ryu², Joel Moss³

Affiliations

¹ Blood Services Section, National Institutes of Health, Clinical Center, Department Transfusion Medicine (CC/DTM), Bethesda, MD, USA.
² Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, USA.
³ Cardiovascular and Pulmonary Branch, National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD, USA [email protected].

PMID: 27103385
DOI: 10.1183/13993003.00410-2016

No abstract available

Publication types

Letter
Research Support, N.I.H., Intramural

MeSH terms

Adult
Blood Donors*
Donor Selection* / methods
Donor Selection* / standards
Female
Humans
Lymphangioleiomyomatosis* / diagnosis
Lymphangioleiomyomatosis* / pathology
Male
Needs Assessment
Neoplasm Staging
Neoplastic Cells, Circulating / pathology*
Transfusion Reaction* / diagnosis
Transfusion Reaction* / etiology
Transfusion Reaction* / prevention & control
United States